方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| COPD评估测试× | 慢性心力衰竭问卷× | |
|---|---|---|
| 领域 | 健康结局 | 健康结局 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 2009 | 2000 |
| 提出者≠ | Paul W. Jones et al. | Luc Guyonnet et al. |
| 类型≠ | Self-report symptom and impact questionnaire | Self-report quality of life questionnaire |
| 开创性文献≠ | Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W. H., & Kline Leidy, N. (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal, 34(3), 648-654. DOI ↗ | Guyonnet, S., Vellas, B., Garry, P. J., & Albarede, J. L. (2000). The Chronic Heart Failure Questionnaire: A pilot study of validity, reliability, and responsiveness. Journal of Cardiac Failure, 6(1), 21-26. link ↗ |
| 别名 | CAT, COPD Assessment Test, COPD Assessment Tool | CHQ, Heart Failure Quality of Life, Chronic Heart Failure QoL |
| 相关 | 4 | 4 |
| 摘要≠ | The COPD Assessment Test (CAT) is a simple, rapid, patient-centered measure of COPD symptom burden and functional impact. Developed by Paul Jones and colleagues in 2009, this 8-item questionnaire captures how COPD affects cough, sputum, chest tightness, breathing difficulty, activity limitation, confidence, sleep, and energy. It is used worldwide in clinical practice to guide disease management decisions and as a primary outcome measure in COPD clinical trials. | The CHQ is a disease-specific quality of life measure for chronic heart failure (CHF). Developed by Luc Guyonnet and colleagues in 2000, this 20-item questionnaire assesses how heart failure affects dyspnea, fatigue, emotional function, and activity limitation. It is used in heart failure clinical trials and research to quantify patient-experienced burden and treatment benefit. |
| ScholarGate数据集 ↗ |
|
|